Family Practice Hospital Internal Medicine Patients 
Physician's Weekly
JUNE 25, 2025
WEDNESDAY, June 25, 2025 (HealthDay News) — Fecal microbiota transplantation (FMT) could be considered as first-line therapy for primary Clostridioides difficile infection (CDI), according to a study published online June 17 in the Annals of Internal Medicine. percent of 51 patients receiving FMT versus 61.2 Additional C.
Physician's Weekly
JUNE 11, 2025
WEDNESDAY, June 11, 2025 (HealthDay News) — Mailed self-collection (SC) kits may increase participation in cervical cancer screening, according to a study published online June 6 in JAMA Internal Medicine. percent in the SC with patient navigation group participated in cervical cancer screening. Montealegre, Ph.D.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Physician's Weekly
JULY 1, 2025
TUESDAY, July 1, 2025 (HealthDay News) — For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, according to a study published online June 24 in the Annals of Internal Medicine. Bruno Linetzky, M.D.,
Physician's Weekly
JUNE 17, 2025
from Massachusetts General Hospital in Boston, and colleagues conducted a retrospective cohort study using electronic health record data from March 1, 2020, to Aug. from Massachusetts General Hospital in Boston, and colleagues conducted a retrospective cohort study using electronic health record data from March 1, 2020, to Aug.
Physician's Weekly
JUNE 11, 2025
The combination pill is the first and only FDA-approved triple combination medication for use as an initial therapy in patients who will likely need multiple drugs to achieve their ideal blood pressure numbers. The most common adverse event reported in patients treated with Widaplik was symptomatic low blood pressure.
Physician's Weekly
JUNE 25, 2025
Starting next year, if a patient switches insurance plans while getting treatment, the new plan must honor the old plan’s prior authorization for at least 90 days. Insurers must provide clearer explanations when care is denied and explain how patients can appeal. AHIP previewed some of the coming changes.
Physician's Weekly
JUNE 25, 2025
The patients were randomly assigned to either substitute with water or continue drinking DBs for the 18-month follow-up. A total of 81 adult women with overweight or obesity (body mass index 27 to 35 kg/m 2 ) and T2D (glycated hemoglobin 6.5 versus −4.85 ± 2.07
Expert insights. Personalized for you.
52 
Let's personalize your content